Oct 30 2026 | By: Houston Concierge
Advanced testing can explore very different questions, from genetics and biological aging to hormone patterns, environmental exposures, Alzheimer's-related biomarkers, esophageal precancer markers, and multi-cancer signals. Houston Concierge Medicine offers eight Testing Kits and advanced testing services, but they are not interchangeable and more testing is not automatically better.
The useful starting point is a clear question. Dr. Gregory S. Burzynski helps patients consider whether a test fits their history, goals, current symptoms, prior results, and preventive-care plan. He can then place the result in context and explain whether another medical step is appropriate.
| Testing service | The question it may help explore |
|---|---|
| Health & Fitness DNA Testing | How genetic traits may relate to fitness, nutrition, recovery, and wellness planning. |
| TruDiagnostic | What epigenetic markers may suggest about biological aging and related patterns. |
| PlasticTox Test Kit | Whether microplastics are detected in the submitted dried-blood sample. |
| LucentAD Complete Alzheimer's Test | How several blood-based Alzheimer's-related biomarkers may support clinical evaluation. |
| EsoGuard Esophageal DNA Test | Whether molecular changes associated with esophageal precancer are detected in an appropriate patient. |
| Total Tox Burden Test Kit | What selected mycotoxin, heavy-metal, and environmental-chemical markers appear in a urine sample. |
| Galleri Cancer Early Detection Test | Whether a blood sample contains a signal associated with multiple cancers and where that signal may originate. |
| Dutch® Hormone Test | What dried-urine measurements show about sex hormones, cortisol patterns, and hormone metabolites. |
This comparison is a starting point, not a recommendation. A physician should determine whether the question is medically useful, whether the patient fits the test's intended population, and how the result would change care.
Health & Fitness DNA Testing explores genetic traits that may be relevant to exercise response, nutrition, recovery, body composition, and other wellness goals. Genetic information describes inherited variants, not a guaranteed outcome. Lifestyle, environment, medical history, and current health still matter.
The most useful conversation focuses on whether the report provides practical information that can be interpreted responsibly rather than treating a genetic tendency as a diagnosis.
TruDiagnostic testing uses epigenetic information to estimate biological-age and aging-related patterns. Biological age is a model based on measured markers. It is not the same as chronological age, and it does not predict exactly how long someone will live.
For an interested patient, Dr. Greg Burzynski can explain which result is being reported, what factors may influence it, and whether repeating the test would answer a meaningful question.
The PlasticTox Test Kit is designed to identify microplastics in a dried-blood sample. The manufacturer notes that the test reports the detected particles in the submitted blood sample and does not describe deposits in organs or tissues.
A result should not be treated as proof that a specific symptom or condition was caused by microplastics. Its value depends on the patient's goal, exposure history, and how the information will be used.
The Total Tox Burden Test Kit is a urine-based panel that measures selected mycotoxins, heavy metals, and environmental chemicals. It can provide exposure-related information that differs from routine laboratory testing.
Exposure markers do not automatically prove toxicity or establish the cause of a health concern. Dr. Greg Burzynski reviews the result with the patient's history, possible exposure sources, other testing, and the limitations of the panel before discussing next steps.
The LucentAD Complete Alzheimer's Test is a blood-based multi-biomarker test designed to support evaluation for Alzheimer's-related pathology. It measures several proteins associated with amyloid, tau, neurodegeneration, and inflammation.
This type of testing belongs in a clinical evaluation rather than a stand-alone self-diagnosis. Memory concerns can have many causes, and the meaning of a biomarker result depends on symptoms, age, history, examination, and other medical information.
The EsoGuard Esophageal DNA Test evaluates a collected esophageal-cell sample for molecular changes associated with Barrett's esophagus and esophageal adenocarcinoma. It is a focused test for appropriate patients, not a general cancer screen.
A positive or concerning result requires medical follow-up, and a result should be interpreted alongside risk factors and the clinician's assessment. Patients with chronic reflux or other concerns can ask Dr. Greg Burzynski whether EsoGuard or another evaluation pathway is more appropriate.
The Galleri Cancer Early Detection Test is a blood test that looks for a signal associated with multiple cancers and predicts the likely tissue or organ connected to a detected signal. The manufacturer states that Galleri does not detect every cancer and is intended to be used in addition to, not instead of, routine screening recommended by a healthcare provider.
A cancer-signal result is not a diagnosis. Follow-up testing is needed to determine whether cancer is present. A no-signal result also does not rule out cancer, which is why established screening and attention to new concerns remain important.
The Dutch® Hormone Test, or Dried Urine Test for Comprehensive Hormones, measures sex hormones, cortisol patterns, and hormone metabolites. Depending on the selected panel, it may also report additional markers.
DUTCH testing can complement other laboratory information, but it is not automatically preferable to blood testing for every question. The right method depends on the hormone, timing, symptoms, medicines, stage of life, and decision the clinician is trying to make.
The Houston Concierge Medicine process is designed to begin with a conversation, not a shopping cart. A patient can describe the question, bring relevant history and prior results, and discuss what a useful answer would change.
This physician-guided approach helps prevent a detailed report from becoming a confusing collection of numbers without a clear medical purpose.
Start with the health question, not the test name. Dr. Greg Burzynski can help determine whether advanced testing is useful and which option is most closely connected to that question.
Possibly, but more data is not automatically more useful. The decision should consider cost, sample requirements, overlapping information, medical relevance, and how each result would affect the plan.
Some tests identify biomarkers, exposure markers, genetic traits, or disease-associated signals. A result may support a clinical evaluation, but it does not automatically establish or exclude a diagnosis. The intended use and limitations differ for every test.
No. Galleri is intended to be used in addition to routine cancer screening recommended by a healthcare provider, not as a replacement.
Houston Concierge Medicine connects testing with physician review. Dr. Greg Burzynski can explain the findings, limitations, and possible next step within the patient's broader health history and goals.
Patients interested in DNA, biological-age, microplastics, Alzheimer's-related, esophageal DNA, toxin-burden, multi-cancer, or hormone testing can begin with the Houston Concierge Medicine testing overview.
Houston Concierge Medicine is located at 9432 Katy Freeway, Suite 400, Houston, Texas 77055. Call or text 713-333-6464, email info@houstonconciergemd.com, or book an appointment online with Dr. Gregory S. Burzynski, Board-Certified Internal Medicine Physician.
Testing note: Advanced tests have different intended uses, limitations, eligibility criteria, and follow-up needs. Results should be reviewed with a qualified healthcare professional and do not replace appropriate routine screening or diagnostic evaluation.